Fadi Chehadah

Search results

• 2017

  Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation

  Corbett, M., Chehadah, F., Biswas, M., Moe-Byrne, T., Palmer, S., Soares, M., Walton, M., Harden, M., Ho, P., Woolacott, N. & Bojke, L., 5 Oct 2017, In: Health technology assessment. 21, 56, p. 1-326 326 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File